Connaught Laboratories, a subsidiary of Rhone-Poulenc Group,...
- Share via
Connaught Laboratories, a subsidiary of Rhone-Poulenc Group, said it will seek Food and Drug Administration approval by the end of the year for a Lyme disease vaccine, citing positive preliminary results. . . . As expected, the European Union appealed a ruling by the World Trade Organization that the EU’s banana trade regulations violate international agreements on free trade. . . . Polo Ralph Lauren Corp. sold shares for $26 each in the second-largest initial public offering this year, raising roughly $767 million in advance of trading today on the NYSE.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.